University of Tübingen
Tübingen, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Retinitis pigmentosa
Cure status
- AAV2-hRPE65v2,voretigene neparvovec-rzylPhase 3 · NCT00999609
- AAV5-hRKp.RPGRPhase 3 · NCT06646289 · NCT05926583
- Genetic: AAV5-hRKp.RPGR Intermediate DosePhase 3 · NCT04794101
- Genetic: AAV5-hRKp.RPGR Low DosePhase 3 · NCT04794101
- LX101Phase 3 · NCT07054632 · NCT06196827 · NCT06212297
- MinocyclinePhase 3 · NCT07082855
- N-acetylcysteinePhase 3 · NCT05537220
- N-acetylcysteine amidePhase 3 · NCT07290530
- NPI-001Phase 3 · NCT07710196
- Sub-Retinal Administration of OCU400-301Phase 3 · NCT06388200
- 1.5 x 10^6 UC-MSC + CMPhase 2/3 · NCT05909488
- 5 x 10^6 UC-MSC + CMPhase 2/3 · NCT05909488
- rAAV2tYF-GRK1-hRPGRcoPhase 2/3 · NCT04850118
- RTx-015Phase 2/3 · NCT07901751 · NCT06460844
- 100 μg KIO-301Phase 2 · NCT06628947
- 50 μg KIO-301Phase 2 · NCT06628947
- Adeno-associated virus vector expressing a human RPGR genePhase 2 · NCT07174726
- AGTC-501 (high dose and modified corticosteroid regimen)Phase 2 · NCT06275620
- AGTC-501 (high dose and standard corticosteroid regimen)Phase 2 · NCT06275620
- AGTC-501 (low dose and standard corticosteroid regimen)Phase 2 · NCT06275620
- human retinal progenitor cellsPhase 2 · NCT06912633
- Intravitreal Injection of UltevursenPhase 2 · NCT07796646 · NCT06627179
- rAAV2tYF-GRK1-RPGRPhase 2 · NCT06333249 · NCT03316560
- 4D-125 IVT InjectionPhase 1/2 · NCT04517149
- AAVB-081Phase 1/2 · NCT06591793
- ACDN-01Phase 1/2 · NCT06467344
- BS01Phase 1/2 · NCT04278131
- Disulfiram 250 mgPhase 1/2 · NCT05626920
- DSP-3077 Retinal Sheet Cohort 1Phase 1/2 · NCT06891885
- DSP-3077 Retinal Sheet Cohort 2Phase 1/2 · NCT06891885
Closest to patients
- Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/IIPhase 2/3 trial: 1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CMPT. Prodia Stem Cell Indonesia (sponsor) · 1 hospital in IndonesiaPhase 2/3Results expected 2027
- A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis PigmentosaPhase 3 trial: MinocyclineZhongshan Ophthalmic Center,Sun Yat-Sen University · Guangzhou, ChinaPhase 3Results expected 2028
- Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)Phase 2/3 trial: RTx-015Ray Therapeutics, Inc. (sponsor) · 14 hospitals in United StatesPhase 2/3Results expected 2028
Choose one to continue
Larger text, shorter lines, fewer blocks, no animation.
Who are you looking for?
Your choice only changes the wording and the order on this page. It stays in this browser.
If you are looking for a relative
Here you will find questions you can ask, help with difficult talks, organisations for carers and your relative's rights.
Questions for your relative's doctor
How do I talk to them about this?
You do not need the right words. Ask what your relative wants to know, and let them set the pace. These pages can help.
Support for you as a carer
Looking after someone is work too. These organisations help carers, and the list further down this page shows helplines by country.
Power of attorney and patient rights, by country
A doctor can share information and a relative can act only with the patient's consent or a legal authority. It is easier to arrange this early.
- Hungary: patient rights representatives (Integrált Jogvédelmi Szolgálat)
- Germany: power of attorney and care directives (Federal Ministry of Justice)
- Austria: adult protection and representation (Ministry of Justice)
- United Kingdom: lasting power of attorney (GOV.UK)
- EU: your rights to healthcare in another EU country (Your Europe)
If you are looking for your child
Children are often treated differently from adults, in specialist centres. Here is where to start.
Before you pay
Parents often receive offers of paid treatment. Please go through this list before you pay for anything.
For patient organisations
You can share or print these pages for your members. They are free and need no account.
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
New and changed trials of the last 30 days, without an account and without tracking.
RSS feedCalendar reminderPublication
Comment on: Impact of Zonular Laxity on the Accuracy of Intraocular Lens Power Calculation Formulas in Cataract Patients With Retinitis Pigmentosa.
Comment on: Impact of Zonular Laxity on the Accuracy of Intraocular Lens Power Calculation Formulas in Cataract Patients With Retinitis Pigmentosa.
American journal of ophthalmology
PubMed · PMID 42987996Publication
Anterior Capsulorhexis Optic Capture for Zonular Insufficiency: Three-Year Outcomes With a Retinitis Pigmentosa Subanalysis.
Anterior Capsulorhexis Optic Capture for Zonular Insufficiency: Three-Year Outcomes With a Retinitis Pigmentosa Subanalysis.
Journal of cataract and refractive surgery
PubMed · PMID 42980597Publication
Static Perimetry-OCT Topographical Overlay Findings in the RUSH2A Study.
Static Perimetry-OCT Topographical Overlay Findings in the RUSH2A Study.
Translational vision science & technology
PubMed · PMID 42986169Publication
Association Between Quality of Life and Visual Function in Inherited Retinal Disease: A Cross-sectional Study in a Retinal Genetics Centre.
Association Between Quality of Life and Visual Function in Inherited Retinal Disease: A Cross-sectional Study in a Retinal Genetics Centre.
Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
PubMed · PMID 42970243Publication
Single-cell transcriptome analysis highlights conserved transcriptional responses across multiple models of Retinitis Pigmentosa.
Single-cell transcriptome analysis highlights conserved transcriptional responses across multiple models of Retinitis Pigmentosa.
Genes & diseases
PubMed · PMID 42990930
Tools for your next step
Questions for your doctor
Pick up to 5 questions for your situation, then print them or take them on your phone.
Choose questionsOrganisations that can help
Helplines, patient groups and support services for you and your family.
Select your country to see the organisations there, starting with the ones closest to you.
Umbrella organisations (they connect national groups)
European Blind Union
European umbrella of national organisations of blind and partially sighted people; advocacy on accessibility, Marrakesh Treaty, braille, mobility; news, webinars, podcasts.
Visit site: European Blind Union
EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
Visit site: EURORDIS – Rare Diseases Europe
Retina International
Global umbrella of patient organisations for inherited and acquired retinal conditions (incl. retinitis pigmentosa, AMD); condition information, patient resources, research and advocacy.
Visit site: Retina International
World Blind Union
Global umbrella of organisations of blind and partially sighted people; advocacy on accessibility, Marrakesh Treaty, braille literacy, inclusive development; scholarships and awards.
Visit site: World Blind Union
General support
For anyone who is ill, whatever the disease: patients' rights and legal aid, crisis lines, hospice and palliative care, care in another EU country, and patient organisations' umbrella bodies.
International
European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
Visit site: European Patients' Forum (EPF)
International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Visit site: International Alliance of Patients' Organizations
Frontlight is not affiliated with these organisations; we list them because they help.
Checked automatically every 90 days.
Find fellow researchers
Groups with active Retinitis pigmentosa work.
University College London
London, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Inserm
Paris, France
Team details appear once the team leader joins.
Is this your team? Claim it
Harvard University
Cambridge, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University of Oxford
Oxford, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Radboud University Medical Center
Nijmegen, Netherlands
Team details appear once the team leader joins.
Is this your team? Claim it
Centre National de la Recherche Scientifique
Paris, France
Team details appear once the team leader joins.
Is this your team? Claim it
University of Basel
Basel, Switzerland
Team details appear once the team leader joins.
Is this your team? Claim it
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Moorfields Eye Hospital
London, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Massachusetts Eye and Ear Infirmary
Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Institute of Molecular and Clinical Ophthalmology Basel
Basel, Switzerland
Team details appear once the team leader joins.
Is this your team? Claim it